Algynomics, Inc. was a Chapel Hill, NC-based pharmaceutical company developing novel opioid treatments for pain. It was acquired by Proove Biosciences in 2016.
The Algynomics platform and its patient cohorts provide researchers with prospective data to identify individuals at increased risk for the development of chronic pain, which will allow targeted preventive efforts.
The Algynomics platform and its patient cohorts provide researchers with prospective data to identify individuals at increased risk for the development of chronic pain, which will allow targeted preventive efforts.
Algynomics, Inc. was a Chapel Hill, NC-based pharmaceutical company developing novel opioid treatments for pain. It was acquired by Proove Biosciences in 2016.
Algynomics, Inc. was a Chapel Hill, NC-based pharmaceutical company developing novel opioid treatments for pain. It was acquired by Proove Biosciences in 2016.